Nurix Therapeutics (NRIX) Leases: 2021-2025
Historic Leases for Nurix Therapeutics (NRIX) over the last 4 years, with Aug 2025 value amounting to $53.0 million.
- Nurix Therapeutics' Leases rose 95.80% to $53.0 million in Q3 2025 from the same period last year, while for Aug 2025 it was $53.0 million, marking a year-over-year increase of 95.80%. This contributed to the annual value of $28.1 million for FY2024, which is 9.64% down from last year.
- Nurix Therapeutics' Leases amounted to $53.0 million in Q3 2025, which was up 814.28% from $5.8 million recorded in Q2 2025.
- Nurix Therapeutics' Leases' 5-year high stood at $53.0 million during Q3 2025, with a 5-year trough of $5.8 million in Q2 2025.
- For the 3-year period, Nurix Therapeutics' Leases averaged around $23.6 million, with its median value being $27.1 million (2024).
- As far as peak fluctuations go, Nurix Therapeutics' Leases spiked by 200.02% in 2024, and later slumped by 79.89% in 2025.
- Nurix Therapeutics' Leases (Quarterly) stood at $14.0 million in 2021, then fell by 11.85% to $12.3 million in 2022, then skyrocketed by 152.26% to $31.1 million in 2023, then fell by 9.64% to $28.1 million in 2024, then soared by 95.80% to $53.0 million in 2025.
- Its last three reported values are $53.0 million in Q3 2025, $5.8 million for Q2 2025, and $26.4 million during Q1 2025.